Clinical Trial

Cardiovascular Risk and Chronic Obstructive Pulmonary Disease

Study acronym: ECO-COPD
Recruiting
View on ClinicalTrials.gov →
Summary
The principal objective of the study is to measure parameters of inflammation, oxidative stress, and vascular, respiratory, and peripheral muscle function parameters, and identify parameters indicative of evolving cardiovascular risk (CVR) in COPD patients, using multivariate analysis.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2017-01-05; most recent amendment 2023-05-22.
Trial Details
NCT Number NCT03014609
Lead Sponsor University Hospital, Grenoble
Conditions Chronic Obstructive Pulmonary Disease
Enrollment 150 participants
Start Date 2017-01-09
Primary Completion 2029-11 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2023-05-23